Real-time Evaluation of Research and Development (R&D) Response to Zika

Overview

Background details to this mission are found in the concept note related to real-time evaluation of the R&D response to Zika. A preliminary scoping mission was conducted in Geneva from 19-22 April 2016. This second mission sought to collect evidence on progress towards agreed milestones and indicators and also to answer a number of generic and specific questions. Details of these are presented in Annex 1 (p11). During the mission, a number of documents were reviewed (see Annex 2, p12) and interviews were held with a number of key informants (see Annex 3, p14). This report is organised as follows. First, it identifies and highlights a number of issues relating to the R&D response to Zika, in general, before considering more detailed issues relating to scientific evidence and progress on R&D related to diagnostics, vaccines, vector control and treatment. It ends with suggested conclusions and recommendations. The extent to which progress towards specific milestones has been assessed and particular questions answered is covered in Annex 4 (p15).